F2 and Thrombocytopenia: Coagulopathy is a commonly recognized feature of the inflammatory response in COVID-19, as 20–50% of hospitalized patients are noted to have abnormalities with elevated D-dimer, prolonged prothrombin time, thrombocytopenia, and abnormal fibrinogen levels.